Among the 3 scored medical research organizations in Gaithersburg, Caring Cross holds 12.2 months of operating reserves (peer median 12.2 months), runs a typical yearly deficit of 25.1% (peers: deficit of 4.0%), and has grown spending 60.9% a year (peers: grown spending 19.0% a year).
In fiscal year 2024 it reported $6,365,843 in revenue and $10,310,690 in expenses, with contributions making up 59.3% of revenue.
Caring Cross is focused upon accelerating the development and implementation of advanced medicines like car-t cell and STEM cell gene therapies. In partnership with like-minded stakeholders, Caring Cross develops and deploys technologies, systems and therapeutic candidates that improve the affordability and accessibility of these potentially life-saving therapies for all patients in need, everywhere.
Largest programs · fiscal year 2024
University of Delaware: Niimbl research development, and testbeds to help the nation prevent, prepare for and respond to coronavirus.$5,530,229 spent · 72.0% of program spending
Tome biosciences and Caring Cross inc. Research collaboration$1,365,313 spent · 17.8% of program spending
The regents of the university of California on behalf of its san francisco campus "ucsf": Complete the phase I iia clinical trial develop a commercial manufacturing process and develop a regulatory pathway plan for decentralized fda approval of the anti-hiv duocar-t cell product.$780,267 spent · 10.2% of program spending
Where each dollar went · fiscal year 2024
Of every dollar it spent, 74¢ went to programs, 26¢ to management and 0¢ to fundraising.
Programs $7,675,809
Management $2,634,881
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
74%
Meets
Compared with Gaithersburg peers
Measure
This organization
Peer median
Operating reserves
12.2 mo
12.2 mo
Typical margin
−25.1%
−4.0%
Spending growth
+60.9% / yr
+19.0% / yr
Debt load
36.4%
30.8%
Peers: the 3 Gaithersburg medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$6,365,843Fiscal year 2024
Expenses$10,310,690Fiscal year 2024
Total assets$16,467,907Fiscal year 2024
Total liabilities$5,991,534Fiscal year 2024
Fiscal year ending December2024
Revenue$6,365,843
Expenses$10,310,690
Net income−$3,944,847
Net assets$10,476,373
Notable sources of revenue
Percent of total revenue
Contributions
$3,773,205
59.3%
Program services
$1,339,248
21.0%
Investment income
$373,031
5.9%
Other (net)
$880,359
13.8%
Assets / debt
Total assets
$16,467,907
Total liabilities
$5,991,534
Net assets
$10,476,373
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$17,750,324
Expenses$4,767,204
Net income$12,983,120
Net assets$14,546,603
Notable sources of revenue
Percent of total revenue
Contributions
$2,243,444
12.6%
Program services
$15,470,452
87.2%
Investment income
$36,428
0.2%
Other (net)
$0
0.0%
Assets / debt
Total assets
$15,530,168
Total liabilities
$983,565
Net assets
$14,546,603
Compensation
Officers and key employees
$390,704
Share of expenses
8.2%
Fiscal year ending December2022
Revenue$2,984,742
Expenses$3,984,826
Net income−$1,000,084
Net assets$1,578,090
Notable sources of revenue
Percent of total revenue
Contributions
$2,899,434
97.1%
Program services
$79,125
2.7%
Investment income
$6,183
0.2%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,942,182
Total liabilities
$364,092
Net assets
$1,578,090
Compensation
Officers and key employees
$495,154
Share of expenses
12.4%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?